These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic Arg-Gly-Asp mimetics. Hardan I, Weiss L, Hershkoviz R, Greenspoon N, Alon R, Cahalon L, Reich S, Slavin S, Lider O. Int J Cancer; 1993 Dec 02; 55(6):1023-8. PubMed ID: 7504656 [Abstract] [Full Text] [Related]
3. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope. Hershkoviz R, Lider O, Bruck R, Aeed H, Greenspoon N, Halpern Z. J Hepatol; 1995 Feb 02; 22(2):158-64. PubMed ID: 7540635 [Abstract] [Full Text] [Related]
4. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope. Bruck R, Hershkoviz R, Lider O, Aeed H, Zaidel L, Matas Z, Barg J, Halpern Z. J Hepatol; 1996 Jun 02; 24(6):731-8. PubMed ID: 8835749 [Abstract] [Full Text] [Related]
5. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp. Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N. Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596 [Abstract] [Full Text] [Related]
6. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence. Greenspoon N, Hershkoviz R, Alon R, Varon D, Shenkman B, Marx G, Federman S, Kapustina G, Lider O. Biochemistry; 1993 Feb 02; 32(4):1001-8. PubMed ID: 8093840 [Abstract] [Full Text] [Related]
7. Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp. Hershkoviz R, Greenspoon N, Mekori YA, Hadari R, Alon R, Kapustina G, Lider O. Clin Exp Immunol; 1994 Feb 02; 95(2):270-6. PubMed ID: 7905794 [Abstract] [Full Text] [Related]
8. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury. Bruck R, Hershkoviz R, Lider O, Shirin H, Aeed H, Halpern Z. Yale J Biol Med; 1997 Feb 02; 70(4):391-402. PubMed ID: 9626759 [Abstract] [Full Text] [Related]
9. Inhibited effect of an RGD peptide hydrogel on the expression of β1-integrin, FAK, and Akt in Tenon's capsule fibroblasts. Chen B, Wu P, Liang L, Zhao C, Wang Z, He L, Zhang R, Xu N. J Biomed Mater Res B Appl Biomater; 2021 Nov 02; 109(11):1857-1865. PubMed ID: 33847460 [Abstract] [Full Text] [Related]
10. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S. J Immunol; 1990 Jul 01; 145(1):59-67. PubMed ID: 1972721 [Abstract] [Full Text] [Related]
11. Novel psi-S-CH2 peptide-bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu-Asp-Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectin. Greenspoon N, Hershkoviz R, Alon R, Gershonov E, Lavie B, Lider O. Int J Pept Protein Res; 1994 May 01; 43(5):417-24. PubMed ID: 7520889 [Abstract] [Full Text] [Related]
12. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. Gehlsen KR, Argraves WS, Pierschbacher MD, Ruoslahti E. J Cell Biol; 1988 Mar 01; 106(3):925-30. PubMed ID: 2450101 [Abstract] [Full Text] [Related]
13. Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. Elices MJ, Urry LA, Hemler ME. J Cell Biol; 1991 Jan 01; 112(1):169-81. PubMed ID: 1986004 [Abstract] [Full Text] [Related]
14. APC0576 decreases production of pro-inflammatory chemokine and extracellular matrix by human Tenon's capsule fibroblasts. Naruse S, Yamada J, Hamuro J, Kobayashi T, Mori K, Kinoshita S. Exp Eye Res; 2004 Aug 01; 79(2):223-30. PubMed ID: 15325569 [Abstract] [Full Text] [Related]
15. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF. J Cell Biochem; 1995 Apr 01; 57(4):680-90. PubMed ID: 7542253 [Abstract] [Full Text] [Related]
16. Arg-Gly-Asp(RGD) peptides inhibit Streptococcus mitis to adhere to fibronectin. Sugano N, Tanaka H, Ito K, Murai S. J Nihon Univ Sch Dent; 1997 Sep 01; 39(3):154-5. PubMed ID: 9354032 [Abstract] [Full Text] [Related]
17. TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellular matrix interactions. Nabeshima K, Inoue T, Shimao Y, Kataoka H, Koono M. Virchows Arch; 1998 Sep 01; 433(3):243-53. PubMed ID: 9769128 [Abstract] [Full Text] [Related]
18. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism. Sheu JR, Lin CH, Peng HC, Huang TF. Peptides; 1994 Sep 01; 15(8):1391-8. PubMed ID: 7700842 [Abstract] [Full Text] [Related]
19. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins. DeRoock IB, Pennington ME, Sroka TC, Lam KS, Bowden GT, Bair EL, Cress AE. Cancer Res; 2001 Apr 15; 61(8):3308-13. PubMed ID: 11309285 [Abstract] [Full Text] [Related]
20. Inhibitory effects of Arg-Gly-Asp (RGD) peptide on cell attachment and migration in a human lens epithelial cell line. Oharazawa H, Ibaraki N, Ohara K, Reddy VN. Ophthalmic Res; 2005 Apr 15; 37(4):191-6. PubMed ID: 15990462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]